Related Experiment Videos
Three-week thyroxine withdrawal: a thyroid-specific quality of life study
Taryn Davids1, Ian J Witterick, Spiro Eski
1From the Departments of Otolaryngology (t.d., i.j.w., s.e., j.l.f.) and Endocrinology (p.g.w.), University of Toronto Medical School and Mount Sinai Hospital, Toronto, Ontario, Canada.
The Laryngoscope
|February 10, 2006
Summary
A 3-week thyroid hormone (T4) withdrawal minimally impacts well-differentiated thyroid cancer patient quality of life (QOL). The test is a simple, cost-effective method for investigating residual or recurrent cancer.
Area of Science:
- Endocrinology
- Oncology
- Quality of Life Research
Background:
- Well-differentiated thyroid cancer (WDTC) management often involves monitoring for recurrence.
- Thyroid hormone (T4) withdrawal is used to induce a hypothyroid state for diagnostic purposes.
- Assessing the impact of diagnostic procedures on patient well-being is crucial.
Purpose of the Study:
- To evaluate the effect of a 3-week T4 withdrawal on the quality of life (QOL) in patients with WDTC.
- To determine if the induced hypothyroid state significantly alters patient-reported QOL outcomes.
Main Methods:
- Prospective survey study involving 181 patients with WDTC.
- Utilized a thyroid-specific QOL survey administered at three time points: baseline, post-T4 withdrawal, and post-therapy resumption.
- Measured QOL across four defined domains.
Main Results:
- A statistically significant, yet very small, reduction in QOL was observed across all four domains after 3 weeks of T4 withdrawal.
- The largest decrease was 2.04 points (out of 10) in the physical well-being category, specifically related to fatigue.
- The observed QOL changes were deemed not clinically significant.
Conclusions:
- The 3-week T4 withdrawal test results in a statistically significant but clinically insignificant decrease in QOL for WDTC patients.
- This diagnostic method is simple, cost-effective, and readily accessible.
- The findings support the use of T4 withdrawal as a practical diagnostic tool without substantial detriment to patient QOL.